SCHEMBL24608980

SCHEMBL24608980

CCCCCCc1cc(-c2ccc(-c3ccc(Cl)cc3)cc2)c(CCCCCC)cc1-c1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.44
CNR2 P34972 2/20 0.42
CNR1 P21554 2/20 0.42
GCGR P47871 1/20 0.42
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 1/20 0.41
ALOX5 P09917 1/20 0.41
TYR P14679 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26954969 0.98 KCNH2 (0.45) KCNH2CNR2CNR1GCGRCYP3A4
SCHEMBL25867877 0.84 LIPG (0.47) MEN1MAPTKMT2AALDH1A1LIPG
SCHEMBL18323121 0.84 RARB (0.46) KCNH2CNR2CNR1GCGRCYP3A4
SCHEMBL24608921 0.81 LIPG (0.45) MEN1MAPTKMT2AALDH1A1LIPG
SCHEMBL18160853 0.81 TYR (0.42) CYP3A4TSHRMEN1MAPTKMT2A
SCHEMBL8746728 0.81 ALOX5 (0.59) CYP3A4TSHRMEN1MAPTKMT2A
SCHEMBL14027824 0.81 TYR (0.42) CYP3A4TSHRMEN1MAPTKMT2A
SCHEMBL14825180 0.81 CNR1 (0.48) CNR2CNR1CYP3A4TSHRMEN1
SCHEMBL8746733 0.81 ALOX5 (0.59) CYP3A4TSHRMEN1MAPTKMT2A
SCHEMBL24608981 0.80 RARB (0.41) KCNH2CNR2CNR1GCGRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213022-A1 COMPOUNDS, LIQUID COMPOSITIONS INCLUDING COMPOUNDS, AND ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213022-A1 COMPOUNDS, LIQUID COMPOSITIONS INCLUDING COMPOUNDS, AND ELECTROLUMINESCENT DEVICES ETV6, ELANE, XPOT KCNH2 1183/4885CNR2 4229/4885CNR1 3793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.